Related Experiment Video
Updated: Jul 16, 2026
08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
Overcoming the challenges in the pharma/biotech industry
Drug News & Perspectives
|March 3, 2007
Summary
Pharmaceutical companies face patent expirations and declining innovation. They are restructuring R&D and pursuing acquisitions and collaborations to strengthen drug pipelines.
Area of Science:
- Pharmaceutical industry
- Drug development
- Biotechnology
Background:
- Declining innovation rates in the pharmaceutical sector.
- Impending patent expirations for major drugs.
- Increased pressure on research and development (R&D) operations.
Purpose of the Study:
- To analyze the strategic responses of pharmaceutical companies to industry challenges.
- To identify key strategies employed to enhance drug pipelines.
- To understand the impact of R&D restructuring on innovation.
Main Methods:
- Review of industry reports and financial statements.
- Analysis of merger and acquisition (M&A) trends.
- Examination of licensing agreements and research collaborations.
Main Results:
- Companies are actively restructuring R&D departments.
- Aggressive pursuit of acquisitions and licensing deals is prevalent.
- Strategic research collaborations are being formed to access new technologies.
Conclusions:
- Pharmaceutical companies are adopting multifaceted strategies to overcome innovation challenges.
- External partnerships and acquisitions are crucial for pipeline growth.
- R&D restructuring is essential for maintaining competitiveness.
Related Concept Videos
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...